VIKING THERAPEUTICS INC (VKTX)

US92686J1060 - Common Stock

42.53  -0.36 (-0.84%)

After market: 42.7 +0.17 (+0.4%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
N/AN/AN/A
949.98%		N/A
328.44%		N/A
302.34%		N/A
180.54%		N/A
93.23%		N/A
49.78%
EBITDA
YoY % growth
N/AN/AN/AN/AN/AN/A
-21.76%		N/A
-30.72%		N/A
-38.37%		N/A
-17.68%		N/A
-47.53%		N/A
-41.68%		N/A
-28.16%		N/A
-24.09%		N/A
-18.55%		N/A
20.27%		N/A
84.99%		N/A
1,999.69%		N/A
105.43%
EBIT
YoY % growth
-23.47M-12M
48.87%		-13.85M
-15.42%		-19.07M
-37.69%		-26.16M
-37.18%		-32.69M
-24.96%		-42.66M
-30.50%		-55.68M
-30.52%		-70.36M
-26.36%		-100.827M
-43.30%		N/A
-44.49%		N/A
-36.72%		N/A
-20.41%		N/A
5.97%		N/A
53.63%		N/A
379.47%		N/A
270.55%		N/A
73.96%
Operating Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/A-3.56-1.00
71.91%		-0.80
20.00%		-0.39
51.25%		-0.36
7.69%		-0.54
-50.00%		-0.72
-33.33%		-0.91
-26.39%		-0.92
-1.10%		N/A
-8.12%		N/A
-51.33%		N/A
-21.13%		N/A
7.70%		N/A
94.04%		N/A
4,227.67%		N/A
159.95%		N/A
83.36%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27
EPS
Q2Q % growth		-0.29
-14.21%		-0.31
-20.63%		-0.34
-72.13%		-0.39
-76.18%		-0.42
-46.47%		-0.31
2.44%		-0.31
11.11%		-0.31
21.05%		-0.31
26.83%		-0.36
-16.67%		-0.43
-40.00%		-0.49
-60.00%
Revenue
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/A
EBITDA
Q2Q % growth		-39.534M
-35.52%		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-39.094M
-33.49%		-48.17M
-41.37%		-54.41M
-59.78%		-61.617M
-68.55%		-69.133M
-76.84%		N/AN/AN/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.22
4.35%		-0.260.0414.36%
Q2 2024
Q2Q % growth		 -0.20
-5.26%		-0.280.0827.38%
Q1 2024
Q2Q % growth		 -0.26
-4.00%		-0.280.028.31%
Q4 2023
Q2Q % growth		 -0.25
3.85%		-0.260.013.25%
Q3 2023
Q2Q % growth		 -0.23
-9.52%		-0.22-0.01-2.92%
Q2 2023
Q2Q % growth		 -0.19
17.39%		-0.200.013.16%
Q1 2023
Q2Q % growth		 -0.25
-19.05%		-0.24-0.01-2.12%
Q4 2022
Q2Q % growth		 -0.26
-62.50%		-0.24-0.02-9.97%
Q3 2022
Q2Q % growth		 -0.21
-23.53%		-0.240.0310.87%
Q2 2022
Q2Q % growth		 -0.23
-15.00%		-0.22-0.01-6.36%
Q1 2022
Q2Q % growth		 -0.21
-10.53%		-0.20-0.01-5.88%
Q4 2021
Q2Q % growth		 -0.16
-6.67%		-0.190.0316.46%
Q3 2021
Q2Q % growth		 -0.17
-30.77%		-0.210.0419.48%
Q2 2021
Q2Q % growth		 -0.20
-53.85%		-0.200.000.78%
Q1 2021
Q2Q % growth		 -0.19
-46.15%		-0.18-0.01-7.14%
Q4 2020
Q2Q % growth		 -0.15
-50.00%		-0.160.013.59%
Q3 2020
Q2Q % growth		 -0.13
-62.50%		-0.150.0216.04%
Q2 2020
Q2Q % growth		 -0.13
-18.18%		-0.150.0210.92%
Q1 2020
Q2Q % growth		 -0.13
-85.71%		-0.12-0.01-4.93%
Q4 2019
Q2Q % growth		 -0.10 -0.130.0323.45%
Q3 2019
Q2Q % growth		 -0.08 -0.130.0537.84%
Q2 2019
Q2Q % growth		 -0.11 -0.09-0.02-19.83%
Q1 2019
Q2Q % growth		 -0.07 -0.090.0219.79%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 5.54% 0.4% 2.05%
RevenueN/A N/A N/A N/A